The Story Behind the Cover Picture
The key role of the hepatic veins collaterals in the modern liver surgery
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:643-644
.
(01 October 2023)
Original Article
Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:645-657
.
(01 October 2023)
Organ meat is a more nutrient dense food than plant foods, or meat consumed as skeletal muscle. We found that higher daily consumption of animal organ meat was associated with lower prevalence of NASH in Chinese adults with biopsy-proven NAFLD.
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:658-670
.
(01 October 2023)
This meta-analysis aimed to compare metabolic, biochemical, and histological parameters for patients with NAFLD undergoing restrictive bariatric procedures vs foregut bypass. Significant histological and metabolic advantages and comparable improvements in biochemical outcomes support the choice of foregut bypass over restrictive bariatric procedures in NAFLD management.
Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:671-681
.
(01 October 2023)
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:682-691
.
(01 October 2023)
The win ratio favored laparoscopic over open resection of colorectal liver metastases relative to 90-day mortality, severity of postoperative complications, time to recurrence and margin status (WR 1.82, 95%CI 1.42-2.34). Laparoscopic resection was favored regardless of sex, age, tumor burden or unilobar/bilobar disease.
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:692-703
.
(01 October 2023)
The win ratio favored laparoscopic over open resection of colorectal liver metastases relative to 90-day mortality, severity of postoperative complications, time to recurrence and margin status (WR 1.82, 95%CI 1.42-2.34). Laparoscopic resection was favored regardless of sex, age, tumor burden or unilobar/bilobar disease.
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:704-714
.
(01 October 2023)
This large retrospective cohort study of 888 patients demonstrates that liver resections can safely be performed in obese patients. Postoperative complications and PHLF of 167 obese patients were comparable to normal weight and overweight patients.
Expert Consensus
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:715-735
.
(01 October 2023)
A group of Hong Kong experts has compiled recommendations for the management of pancreatic cystic lesions (PCL). Their recommendations cover diagnosis, stratification, and treatment of patients, including the use of pancreatic enzyme replacement therapy for those who develop pancreatic exocrine insufficiency.
French Editorial Commentary from the ACHBPT
Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:736-739
.
(01 October 2023)
Modified Appleby: experience improves short-term results, but is it enough?
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:740-742
.
(01 October 2023)
Editorial Commentary
Expert consensus—promoting clinical excellence and ultimately benefitting patients
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:743-745
.
(01 October 2023)
AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:746-751
.
(01 October 2023)
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:752-755
.
(01 October 2023)
A critical review of pancreatectomy with concomitant superior mesenteric artery resection and intestinal autotransplantation
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:756-758
.
(01 October 2023)
Tropifexor, a selective non-acid farnesoid X receptor agonist, improved nonalcoholic steatohepatitis in a phase 2 trial, but several issues remain to be resolved
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:759-762
.
(01 October 2023)
Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:763-767
.
(01 October 2023)
Hepatitis B down under: consensus recommendations from the Gastroenterological Society of Australia
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:768-771
.
(01 October 2023)
Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:772-775
.
(01 October 2023)
Guidelines on cholangioscopy for indeterminate biliary strictures: one step closer to consensus
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:776-779
.
(01 October 2023)
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:780-784
.
(01 October 2023)
The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:785-789
.
(01 October 2023)
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:790-794
.
(01 October 2023)
Mucosa-associated microbiota alterations in primary sclerosing cholangitis (PSC) before and after liver transplantation—who is calling the shots?
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:795-797
.
(01 October 2023)
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:798-803
.
(01 October 2023)
Glisson's Capsule in The Avicenna’s Canon of Medicine
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:804-805
.
(01 October 2023)
Advances in the construction of in vitro liver tissue models using 3D bioprinting technology
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:806-809
.
(01 October 2023)
Editorial
Advancing prognostic precision in hepatocellular carcinoma: a paradigm shift towards machine learning
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:810-812
.
(01 October 2023)
The efforts are worth the benefits for laparoscopic liver resection
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:813-814
.
(01 October 2023)
Concerns about how to simultaneously determine microvascular invasion and pathological response after transarterial chemoembolization before hepatocellular carcinoma surgery
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:815-817
.
(01 October 2023)
Letter to the Editor
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:818-821
.
(01 October 2023)
Images in Clinical Medicine
Isolated intrahepatic mass after abdominal trauma
HepatoBiliary Surgery and Nutrition
2023;
12
(5)
:822-823
.
(01 October 2023)
